 | • レポートコード：D005-03095 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血漿誘導体の世界市場を広く調査・分析し、今後の市場展望をまとめております。血漿誘導体の種類別市場規模（アルブミン、第VIII因子、第IX因子、免疫グロブリン、過免疫グロブリン、その他）、用途別市場規模（病院、クリニック、その他のエンドユーザー）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Grifols、Octapharma AG、Biotest AG、SK Plasma、LFB、Fusion Health Care、Takeda、Baxter International、Green Cross Corporation、CSL Limited、Hualan Biological Engineering、China Biologic Products、Bayer AG、Kedrion Biopharma、BDI Pharma ・地域別グローバル市場分析 2015年-2020年 ・血漿誘導体の北米市場（アメリカ、カナダ、メキシコ） ・血漿誘導体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血漿誘導体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血漿誘導体の南米市場（ブラジル、アルゼンチン） ・血漿誘導体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アルブミン、第VIII因子、第IX因子、免疫グロブリン、過免疫グロブリン、その他 ・用途別分析：病院、クリニック、その他のエンドユーザー ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Blood Plasma Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 38210 million by 2025, from USD 30860 million in 2019.
The Blood Plasma Derivatives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Blood Plasma Derivatives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Blood Plasma Derivatives market has been segmented into
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
By Application, Blood Plasma Derivatives has been segmented into:
Hospitals
Clinics
Other End Users
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Blood Plasma Derivatives market presented in the report. This section sheds light on the sales growth of different regional and country-level Blood Plasma Derivatives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Blood Plasma Derivatives market.
The report offers in-depth assessment of the growth and other aspects of the Blood Plasma Derivatives market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Blood Plasma Derivatives Market Share Analysis
Blood Plasma Derivatives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Blood Plasma Derivatives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Blood Plasma Derivatives sales, revenue and market share for each player covered in this report.
The major players covered in Blood Plasma Derivatives are:
Grifols
Octapharma AG
Biotest AG
SK Plasma
LFB
Fusion Health Care
Takeda
Baxter International
Green Cross Corporation
CSL Limited
Hualan Biological Engineering
China Biologic Products
Bayer AG
Kedrion Biopharma
BDI Pharma
Among other players domestic and global, Blood Plasma Derivatives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Plasma Derivatives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Blood Plasma Derivatives, with price, sales, revenue and global market share of Blood Plasma Derivatives in 2018 and 2019.
Chapter 3, the Blood Plasma Derivatives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Plasma Derivatives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Blood Plasma Derivatives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Blood Plasma Derivatives sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Blood Plasma Derivatives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blood Plasma Derivatives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Albumin
1.2.3 Factor VIII
1.2.4 Factor IX
1.2.5 Immunoglobulin
1.2.6 Hyperimmune Globulin
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Blood Plasma Derivatives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other End Users
1.4 Overview of Global Blood Plasma Derivatives Market
1.4.1 Global Blood Plasma Derivatives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Grifols SWOT Analysis
2.1.4 Grifols Product and Services
2.1.5 Grifols Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Octapharma AG
2.2.1 Octapharma AG Details
2.2.2 Octapharma AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Octapharma AG SWOT Analysis
2.2.4 Octapharma AG Product and Services
2.2.5 Octapharma AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biotest AG
2.3.1 Biotest AG Details
2.3.2 Biotest AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biotest AG SWOT Analysis
2.3.4 Biotest AG Product and Services
2.3.5 Biotest AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 SK Plasma
2.4.1 SK Plasma Details
2.4.2 SK Plasma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 SK Plasma SWOT Analysis
2.4.4 SK Plasma Product and Services
2.4.5 SK Plasma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 LFB
2.5.1 LFB Details
2.5.2 LFB Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 LFB SWOT Analysis
2.5.4 LFB Product and Services
2.5.5 LFB Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Fusion Health Care
2.6.1 Fusion Health Care Details
2.6.2 Fusion Health Care Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Fusion Health Care SWOT Analysis
2.6.4 Fusion Health Care Product and Services
2.6.5 Fusion Health Care Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda SWOT Analysis
2.7.4 Takeda Product and Services
2.7.5 Takeda Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Baxter International
2.8.1 Baxter International Details
2.8.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Baxter International SWOT Analysis
2.8.4 Baxter International Product and Services
2.8.5 Baxter International Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Green Cross Corporation
2.9.1 Green Cross Corporation Details
2.9.2 Green Cross Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Green Cross Corporation SWOT Analysis
2.9.4 Green Cross Corporation Product and Services
2.9.5 Green Cross Corporation Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 CSL Limited
2.10.1 CSL Limited Details
2.10.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 CSL Limited SWOT Analysis
2.10.4 CSL Limited Product and Services
2.10.5 CSL Limited Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hualan Biological Engineering
2.11.1 Hualan Biological Engineering Details
2.11.2 Hualan Biological Engineering Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hualan Biological Engineering SWOT Analysis
2.11.4 Hualan Biological Engineering Product and Services
2.11.5 Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 China Biologic Products
2.12.1 China Biologic Products Details
2.12.2 China Biologic Products Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 China Biologic Products SWOT Analysis
2.12.4 China Biologic Products Product and Services
2.12.5 China Biologic Products Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bayer AG
2.13.1 Bayer AG Details
2.13.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Bayer AG SWOT Analysis
2.13.4 Bayer AG Product and Services
2.13.5 Bayer AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Kedrion Biopharma
2.14.1 Kedrion Biopharma Details
2.14.2 Kedrion Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Kedrion Biopharma SWOT Analysis
2.14.4 Kedrion Biopharma Product and Services
2.14.5 Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 BDI Pharma
2.15.1 BDI Pharma Details
2.15.2 BDI Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 BDI Pharma SWOT Analysis
2.15.4 BDI Pharma Product and Services
2.15.5 BDI Pharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Blood Plasma Derivatives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Blood Plasma Derivatives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Blood Plasma Derivatives Manufacturer Market Share in 2019
3.3.2 Top 6 Blood Plasma Derivatives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Blood Plasma Derivatives Sales, Revenue and Market Share by Regions
4.1.1 Global Blood Plasma Derivatives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Blood Plasma Derivatives Revenue and Market Share by Regions (2015-2020)
4.2 North America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
4.3 Europe Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
4.5 South America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Blood Plasma Derivatives Sales, Revenue and Market Share by Country
5.1.1 North America Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)
5.1.2 North America Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)
5.2 United States Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
5.3 Canada Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
5.4 Mexico Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Blood Plasma Derivatives Sales, Revenue and Market Share by Country
6.1.1 Europe Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)
6.2 Germany Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
6.3 UK Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
6.4 France Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
6.5 Russia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
6.6 Italy Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Blood Plasma Derivatives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Blood Plasma Derivatives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Blood Plasma Derivatives Revenue and Market Share by Regions (2015-2020)
7.2 China Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7.3 Japan Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7.4 Korea Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7.5 India Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
7.7 Australia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Blood Plasma Derivatives Sales, Revenue and Market Share by Country
8.1.1 South America Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)
8.1.2 South America Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
8.3 Argentina Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Blood Plasma Derivatives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
9.3 Turkey Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
9.4 Egypt Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
9.5 South Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Blood Plasma Derivatives Sales and Market Share by Type (2015-2020)
10.2 Global Blood Plasma Derivatives Revenue and Market Share by Type (2015-2020)
10.3 Global Blood Plasma Derivatives Price by Type (2015-2020)
11 Global Blood Plasma Derivatives Market Segment by Application
11.1 Global Blood Plasma Derivatives Sales Market Share by Application (2015-2020)
11.2 Global Blood Plasma Derivatives Revenue Market Share by Application (2015-2020)
11.3 Global Blood Plasma Derivatives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Blood Plasma Derivatives Sales, Revenue and Growth Rate (2021-2025)
12.2 Blood Plasma Derivatives Market Forecast by Regions (2021-2025)
12.2.1 North America Blood Plasma Derivatives Market Forecast (2021-2025)
12.2.2 Europe Blood Plasma Derivatives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Blood Plasma Derivatives Market Forecast (2021-2025)
12.2.4 South America Blood Plasma Derivatives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Blood Plasma Derivatives Market Forecast (2021-2025)
12.3 Blood Plasma Derivatives Market Forecast by Type (2021-2025)
12.3.1 Global Blood Plasma Derivatives Sales Forecast by Type (2021-2025)
12.3.2 Global Blood Plasma Derivatives Market Share Forecast by Type (2021-2025)
12.4 Blood Plasma Derivatives Market Forecast by Application (2021-2025)
12.4.1 Global Blood Plasma Derivatives Sales Forecast by Application (2021-2025)
12.4.2 Global Blood Plasma Derivatives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Blood Plasma Derivatives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Blood Plasma Derivatives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Grifols Basic Information, Manufacturing Base and Competitors
Table 8. Grifols Blood Plasma Derivatives Major Business
Table 9. Grifols Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 10. Grifols SWOT Analysis
Table 11. Grifols Blood Plasma Derivatives Product and Services
Table 12. Grifols Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma AG Blood Plasma Derivatives Major Business
Table 15. Octapharma AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 16. Octapharma AG SWOT Analysis
Table 17. Octapharma AG Blood Plasma Derivatives Product and Services
Table 18. Octapharma AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biotest AG Basic Information, Manufacturing Base and Competitors
Table 20. Biotest AG Blood Plasma Derivatives Major Business
Table 21. Biotest AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 22. Biotest AG SWOT Analysis
Table 23. Biotest AG Blood Plasma Derivatives Product and Services
Table 24. Biotest AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. SK Plasma Basic Information, Manufacturing Base and Competitors
Table 26. SK Plasma Blood Plasma Derivatives Major Business
Table 27. SK Plasma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 28. SK Plasma SWOT Analysis
Table 29. SK Plasma Blood Plasma Derivatives Product and Services
Table 30. SK Plasma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. LFB Basic Information, Manufacturing Base and Competitors
Table 32. LFB Blood Plasma Derivatives Major Business
Table 33. LFB Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 34. LFB SWOT Analysis
Table 35. LFB Blood Plasma Derivatives Product and Services
Table 36. LFB Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Fusion Health Care Basic Information, Manufacturing Base and Competitors
Table 38. Fusion Health Care Blood Plasma Derivatives Major Business
Table 39. Fusion Health Care Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 40. Fusion Health Care SWOT Analysis
Table 41. Fusion Health Care Blood Plasma Derivatives Product and Services
Table 42. Fusion Health Care Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Blood Plasma Derivatives Major Business
Table 45. Takeda Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 46. Takeda SWOT Analysis
Table 47. Takeda Blood Plasma Derivatives Product and Services
Table 48. Takeda Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Baxter International Basic Information, Manufacturing Base and Competitors
Table 50. Baxter International Blood Plasma Derivatives Major Business
Table 51. Baxter International Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 52. Baxter International SWOT Analysis
Table 53. Baxter International Blood Plasma Derivatives Product and Services
Table 54. Baxter International Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Green Cross Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Green Cross Corporation Blood Plasma Derivatives Major Business
Table 57. Green Cross Corporation Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 58. Green Cross Corporation SWOT Analysis
Table 59. Green Cross Corporation Blood Plasma Derivatives Product and Services
Table 60. Green Cross Corporation Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 62. CSL Limited Blood Plasma Derivatives Major Business
Table 63. CSL Limited Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 64. CSL Limited SWOT Analysis
Table 65. CSL Limited Blood Plasma Derivatives Product and Services
Table 66. CSL Limited Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 68. Hualan Biological Engineering Blood Plasma Derivatives Major Business
Table 69. Hualan Biological Engineering Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 70. Hualan Biological Engineering SWOT Analysis
Table 71. Hualan Biological Engineering Blood Plasma Derivatives Product and Services
Table 72. Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 74. China Biologic Products Blood Plasma Derivatives Major Business
Table 75. China Biologic Products Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 76. China Biologic Products SWOT Analysis
Table 77. China Biologic Products Blood Plasma Derivatives Product and Services
Table 78. China Biologic Products Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 80. Bayer AG Blood Plasma Derivatives Major Business
Table 81. Bayer AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 82. Bayer AG SWOT Analysis
Table 83. Bayer AG Blood Plasma Derivatives Product and Services
Table 84. Bayer AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 86. Kedrion Biopharma Blood Plasma Derivatives Major Business
Table 87. Kedrion Biopharma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 88. Kedrion Biopharma SWOT Analysis
Table 89. Kedrion Biopharma Blood Plasma Derivatives Product and Services
Table 90. Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. BDI Pharma Basic Information, Manufacturing Base and Competitors
Table 92. BDI Pharma Blood Plasma Derivatives Major Business
Table 93. BDI Pharma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)
Table 94. BDI Pharma SWOT Analysis
Table 95. BDI Pharma Blood Plasma Derivatives Product and Services
Table 96. BDI Pharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Blood Plasma Derivatives Sales by Manufacturer (2018-2019) (K MT)
Table 98. Global Blood Plasma Derivatives Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Blood Plasma Derivatives Sales by Regions (2015-2020) (K MT)
Table 100. Global Blood Plasma Derivatives Sales Market Share by Regions (2015-2020)
Table 101. Global Blood Plasma Derivatives Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)
Table 103. North America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)
Table 104. North America Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)
Table 106. Europe Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)
Table 107. Europe Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)
Table 108. Europe Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Blood Plasma Derivatives Sales by Regions (2015-2020) (K MT)
Table 110. Asia-Pacific Blood Plasma Derivatives Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Blood Plasma Derivatives Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)
Table 113. South America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)
Table 114. South America Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)
Table 117. Middle East & Africa Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)
Table 120. Global Blood Plasma Derivatives Sales by Type (2015-2020) (K MT)
Table 121. Global Blood Plasma Derivatives Sales Share by Type (2015-2020)
Table 122. Global Blood Plasma Derivatives Revenue by Type (2015-2020) (USD Million)
Table 123. Global Blood Plasma Derivatives Revenue Share by Type (2015-2020)
Table 124. Global Blood Plasma Derivatives Sales by Application (2015-2020) (K MT)
Table 125. Global Blood Plasma Derivatives Sales Share by Application (2015-2020)
Table 126. Global Blood Plasma Derivatives Sales Forecast by Regions (2021-2025) (K MT)
Table 127. Global Blood Plasma Derivatives Market Share Forecast by Regions (2021-2025)
Table 128. Global Blood Plasma Derivatives Sales Forecast by Type (2021-2025) (K MT)
Table 129. Global Blood Plasma Derivatives Market Share Forecast by Type (2021-2025)
Table 130. Global Blood Plasma Derivatives Sales Forecast by Application (2021-2025)
Table 131. Global Blood Plasma Derivatives Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Blood Plasma Derivatives Picture
Figure 2. Global Sales Market Share of Blood Plasma Derivatives by Type in 2019
Figure 3. Albumin Picture
Figure 4. Factor VIII Picture
Figure 5. Factor IX Picture
Figure 6. Immunoglobulin Picture
Figure 7. Hyperimmune Globulin Picture
Figure 8. Others Picture
Figure 9. Blood Plasma Derivatives Sales Market Share by Application in 2018
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Other End Users Picture
Figure 13. Global Blood Plasma Derivatives Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Blood Plasma Derivatives Sales Market Share by Manufacturer in 2019
Figure 34. Global Blood Plasma Derivatives Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Blood Plasma Derivatives Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Blood Plasma Derivatives Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Blood Plasma Derivatives Revenue Market Share by Regions (2015-2020)
Figure 41. Global Blood Plasma Derivatives Revenue Market Share by Regions in 2018
Figure 42. North America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
Figure 43. Europe Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
Figure 45. South America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)
Figure 47. North America Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)
Figure 49. North America Blood Plasma Derivatives Sales Market Share by Countries in 2018
Figure 50. North America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Blood Plasma Derivatives Revenue Market Share by Countries in 2018
Figure 52. United States Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Blood Plasma Derivatives Revenue Market Share by Countries in 2019
Figure 58. Germany Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Blood Plasma Derivatives Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Blood Plasma Derivatives Revenue Market Share by Regions 2019
Figure 66. China Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Blood Plasma Derivatives Sales Market Share by Countries in 2019
Figure 73. South America Blood Plasma Derivatives Revenue Market Share by Countries in 2019
Figure 74. Brazil Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Blood Plasma Derivatives Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Blood Plasma Derivatives Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Blood Plasma Derivatives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
コロイド（血液血漿）の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Colloids (Blood Plasma) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 400.3 million by 2025, from USD 441 million in 2019. The Colloid…- アルテミシニン誘導体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Artemisinin Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Artemisinin Derivativ…
- 採血チューブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Blood Collection Tube market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Collection Tube m…
- アルギン酸塩及び誘導体の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Alginates & Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 484.5 million by 2025, from USD 423.1 million in 2019. The Algina…
- セルロースエーテル及びその誘導体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cellulose Ether and Its Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cellulose…